Implications of geographical variation on clinical outcomes of cardiovascular trials-Reference-Cited by-同舟云学术

Implications of geographical variation on clinical outcomes of cardiovascular trials

Published:2012-09 Issue:3 Volume:164 Page:303-312
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Mentz Robert J.,Kaski Juan-Carlos,Dan Gheorghe-Andrei,Goldstein Sidney,Stockbridge Norman,Alonso-Garcia Angeles,Ruilope Luis M.,Martinez Felipe A.,Zannad Faiez,Pitt Bertram,Fiuzat Mona,O'Connor Christopher M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference56 articles.

1. Ethical and scientific implications of the globalization of clinical research;Glickman;N Engl J Med,2009

2. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial;Wedel;Am Heart J,2001

3. Globalization of cardiovascular clinical research: the balance between meeting medical needs and maintaining scientific standards;Stough;Am Heart J,2007

4. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group;N Engl J Med,1987

5. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators;N Engl J Med,1991

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and without diabetes mellitus: A meta-analysis of placebo-controlled randomized controlled trials;Journal of Clinical Lipidology;2024-07

2. Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial;Diabetes, Obesity and Metabolism;2024-06-19

3. Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Treated Patients;Kidney Medicine;2023-07

4. Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Naïve Patients;Kidney Medicine;2023-07

5. Current concepts in coronary artery revascularisation;The Lancet;2023-05